The winners of IBIS Capital’s 2024 HealthTechX Awards were revealed on stage at the HealthTechX Summit on 28th February. Celebrating innovation, impact and growth, the awards recognise companies that are using technology to advance healthcare and support patients, providers, payers, and pharma in delivering more efficient care for better outcomes.
The two winners were selected from a pool of finalists across two categories based on the companies’ growth stage. Read on to find out more about the winners and finalists…
Lindus Health is a next-generation CRO running radically faster, more reliable clinical trials for life science pioneers. We do this thanks to a unique software platform, access to 20 million Electronic Health Records and a world-class clinical operation team. We handle the end-to-end execution of clinical studies, including design, patient recruitment, clinical data capture, monitoring and project management. We have helped over 80 sponsors run entire clinical studies up to 3x faster than typical CROs.
Our IBIS Capital judging panel commented, “When we think about innovations in the drug discovery and development pipeline, so much attention has gone to AI-based drug discovery solutions. The reality is that the costliest and longest phase of bringing new therapeutics to patients is actually the clinical development process. Lindus Health is a next-generation contract research organisation which has helped over 80 clients run entire clinical studies up to three times faster than traditional providers. These trials have been run across a wide range of conditions including type 2 diabetes and COPD, allowing patients to benefit from new treatments more quickly.”
“Everyone agrees that the clinical research space is in need of change, yet clinical research sponsors can be reluctant to try something new,” said Co-Founder, Meri Beckwith. “That’s why we’re so thrilled to win the HealthTechX Innovator award, as it helps shine a light on the impact we’ve been able to have in conducting faster, more reliable clinical trials for groundbreaking treatments. It’s nice to have our hard work recognised alongside some other fantastic winners and nominees this year. Thank you to the judges and the HealthTechX team for making it happen!”
Evergreen Life is dedicated to improving the health and happiness of the population, and reducing pressure on our healthcare systems, by empowering people to take control of their own health. Central to our focus on ‘People Powered Health’ is how we enable people to curate their own personal health record and share this information currently held by different health organisations through a digital app-based solution.
“This company is solving real problems within the UK healthcare system,” the IBIS Capital judging panel commented. “Of the long list of problems that impact the NHS, waiting lists come at the top of the list. Evergreen Life’s central belief is that the patient should be at the centre of all healthcare decisions, and that this shift can improve the system’s efficiencies. By combining electronic health records, telemedicine, precision diagnostics and monitoring, Evergreen Life empowers patients to make informed decisions and eases pressure on both primary and secondary care ecosystems in the UK. In one trust, waiting times for referrals were reduced from 33 weeks to 2 days — showing true impact in action.”
“I know our team at Evergreen work so hard, often in difficult circumstances, to mean people are healthier and happier,” said Founder & CEO, Stephen Critchlow. “This award will mean so much to them to know that we are growing and seen by others to be in a position to keep growing. We would like to see the whole health system globally benefit from what we are doing.”
Find out more about the HealthTechX Awards here.